Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.
Schneider C, Bothner U, Jick SS, Meier CR. Schneider C, et al. Among authors: bothner u. Eur J Epidemiol. 2010 Apr;25(4):253-60. doi: 10.1007/s10654-010-9435-7. Epub 2010 Feb 27. Eur J Epidemiol. 2010. PMID: 20191376
COPD and the risk of depression.
Schneider C, Jick SS, Bothner U, Meier CR. Schneider C, et al. Among authors: bothner u. Chest. 2010 Feb;137(2):341-7. doi: 10.1378/chest.09-0614. Epub 2009 Oct 3. Chest. 2010. PMID: 19801582
Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD.
Schneider C, Jick SS, Bothner U, Meier CR. Schneider C, et al. Among authors: bothner u. COPD. 2010 Jun;7(3):172-8. doi: 10.3109/15412555.2010.481698. COPD. 2010. PMID: 20486815
One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis.
McGarvey L, Niewoehner D, Magder S, Sachs P, Tetzlaff K, Hamilton A, Korducki L, Bothner U, Vogelmeier C, Koch A, Ferguson GT. McGarvey L, et al. Among authors: bothner u. COPD. 2015;12(5):484-93. doi: 10.3109/15412555.2014.991864. Epub 2015 Feb 18. COPD. 2015. PMID: 25692310 Free PMC article. Clinical Trial.
Cancer risk in patients with chronic obstructive pulmonary disease.
Schneider C, Jick SS, Bothner U, Meier CR. Schneider C, et al. Among authors: bothner u. Pragmat Obs Res. 2010 Nov 24;1:15-23. doi: 10.2147/POR.S13176. eCollection 2010. Pragmat Obs Res. 2010. PMID: 27774005 Free PMC article.
Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
Buhl R, Magder S, Bothner U, Tetzlaff K, Voß F, Loaiza L, Vogelmeier CF, McGarvey L. Buhl R, et al. Among authors: bothner u. Respir Med. 2017 Jan;122:58-66. doi: 10.1016/j.rmed.2016.11.011. Epub 2016 Nov 14. Respir Med. 2017. PMID: 27993292 Clinical Trial.
Effect of long-acting β2-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patients.
Andreas S, Bothner U, Trampisch M, Haensel M, Buhl R, Alter P. Andreas S, et al. Among authors: bothner u. Pulm Pharmacol Ther. 2018 Oct;52:1-6. doi: 10.1016/j.pupt.2018.08.002. Epub 2018 Aug 2. Pulm Pharmacol Ther. 2018. PMID: 30077810 Free article. Clinical Trial.
Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials.
Ferguson GT, Buhl R, Bothner U, Hoz A, Voß F, Anzueto A, Calverley PMA. Ferguson GT, et al. Among authors: bothner u. Respir Med. 2018 Oct;143:67-73. doi: 10.1016/j.rmed.2018.08.012. Epub 2018 Aug 28. Respir Med. 2018. PMID: 30261995 Free article.
Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease.
Bai C, Ichinose M, Lee SH, Lee KH, Jöns O, Bothner U, Zhao Y, Buhl R. Bai C, et al. Among authors: bothner u. Int J Chron Obstruct Pulmon Dis. 2017 Nov 20;12:3329-3339. doi: 10.2147/COPD.S137719. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29200840 Free PMC article. Clinical Trial.
Effects of epinephrine and vasopressin on median fibrillation frequency and defibrillation success in a porcine model of cardiopulmonary resuscitation.
Strohmenger HU, Lindner KH, Prengel AW, Pfenninger EG, Bothner U, Lurie KG. Strohmenger HU, et al. Among authors: bothner u. Resuscitation. 1996 Feb;31(1):65-73. doi: 10.1016/0300-9572(95)00899-3. Resuscitation. 1996. PMID: 8701111
METHODS AND RESULTS: After 4 min of VF and 3 min of CPR, 14 pigs received 0.045 mg/kg epinephrine or 0.4 U/kg vasopressin. Using radio-labeled microspheres, median myocardial blood flow during CPR before, and 90 s and 5 min after drug administration (DA) was 15.5 (12.6, 23 …
METHODS AND RESULTS: After 4 min of VF and 3 min of CPR, 14 pigs received 0.045 mg/kg epinephrine or 0.4 U/kg vasopressin. Using radi …
46 results
Jump to page
Feedback